LUGANO Switzerland – The ESMO Immuno-Oncology Congress 2020, the European platform dedicated to the development and use of immunotherapies for cancer treatment, will be held as a virtual meeting.

The Scientific programme will provide a comprehensive overview of cancer treatment, from the basics of immunotherapies to the latest research results, and from the understanding of the different treatment options to the management of toxicities and interpretation of new data.

Programme highlights

  • Future of adjuvant and neoadjuvant treatment
  • Tumour microenvironment
  • Development of novel therapeutics in preclinical and early stages
  • Interfaces between COVID-19 and immunotherapy in cancer patients
  • Updates and novel data in gastrointestinal, lung, breast and gynecological cancers

ESMO welcomes media interested in reporting from the ESMO events and on cancer issues. Only through the official accreditation process with the ESMO Media Registration Form, accredited media representatives will be able to access scientific and educational sessions (live streamed and on-demand), live Q&A with invited speakers and e-poster presenters, e-posters, virtual exhibition and industry satellite symposia, Congress webcasts. 

Further information

ESMO Press Office

Notes to Editors

Please make sure to use the official name of the meeting in your reports: ESMO Immuno-Oncology Virtual Congress 2020

Official Congress hashtag: #ESMOImmuno20